Table 4: Generalized Linear Mixed Models for relationship of identified themes on supplement disclosure and nondisclosure (n = 466 supplements).
Estimate for relationship to supplement disclosure* | Standard Error | p-value | |
Themes related to disclosure | |||
Interaction during visit | 1.89 | 0.45 | < 0.001 |
Discussion topic | 2.63 | 0.43 | < 0.001 |
Visit characteristics | - 0.65 | 1.06 | 0.54 |
Concerns about supplement | 1.22 | 0.47 | < 0.01 |
Circumstances of supplement use | - 0.09 | 1.00 | 0.93 |
Medication related | 2.79 | 0.79 | < 0.001 |
Medical condition | - 1.04 | 1.47 | 0.48 |
Provider characteristics | 2.28 | 0.66 | < 0.001 |
Patient convictions | |||
Themes related to nondisclosure | |||
Interaction during visit | - 3.48 | 1.07 | < 0.01 |
Visit characteristics | - 3.94 | 0.74 | < 0.001 |
Organizational and procedural factors | - 3.63 | 0.67 | < 0.001 |
Circumstances of supplement use | - 1.85 | 0.59 | < 0.01 |
Medical condition | |||
Provider characteristics | - 1.53 | 0.75 | 0.04 |
Patient convictions | - 2.51 | 0.69 | < 0.001 |
Patient confidence | - 0.78 | 0.63 | 0.02 |
Did not cross mind | - 4.72 | 1.19 | < 0.001 |
*reference group = supplement nondisclosure.